HURA TuHURA Biosciences, Inc./NV
Price Chart
Executive Summary
TuHURA Biosciences completed its acquisition of Kineta and released updated pro forma financials showing a combined net loss of $34.6 million for 2025. The company also approved 2025 bonuses and 5% salary increases for its CEO and CFO.
Actionable Insight
Monitor integration progress of Kineta acquisition and upcoming clinical trial developments, as the combined entity continues to operate at a significant loss despite executive compensation increases.
Key Facts
- Completed acquisition of Kineta on June 30, 2025, with TuHURA as accounting acquirer
- Pro forma net loss attributable to common stockholders for 2025 was $34.6 million
- Weighted average shares outstanding increased to 54.3 million post-merger
- CEO James Bianco received $490,536 bonus and 5% salary increase to $605,956
- CFO Dan Dearborn received $163,393 bonus and 5% salary increase to $403,676
Financial Impact
Pro forma net loss of $34.6 million for 2025 with 54.3 million weighted average shares outstanding
Risk Factors
- Continued significant net losses post-acquisition
- Dilution from increased share count and warrant issuances
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-147660 |
| Document: d131347d8k.htm | 0001193125-26-147660 |
| Document: 0001193125-26-147660-index-headers.html | 0001193125-26-147660 |
| Document: 0001193125-26-147660-index.html | 0001193125-26-147660 |
| Document: 0001193125-26-147660.txt | 0001193125-26-147660 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
16d ago
|
8-K
| $2.24 $1.97 | ▼ −12.28% | ▼ −9.53% | $2.32 (+3.57%) |
|
May 15, 2026
4w ago
|
8-K
| $2.55 $2.45 | ▼ −3.92% | ▼ −5.54% | $2.32 (−9.02%) |
|
Apr 22, 2026
7w ago
|
8-K
| $2.68 $2.15 | ▼ −19.96% | ▼ −20.02% | $2.32 (−13.43%) |
|
Apr 8, 2026
9w ago
|
424B5
| $1.96 $2.96 | ▼ −51.02% | ▼ −47.83% | $2.32 (−18.37%) |
|
Apr 8, 2026
9w ago
|
8-K
| $1.96 $2.96 | ▲ +51.02% | ▲ +47.83% | $2.32 (+18.37%) |
|
Apr 1, 2026
10w ago
|
8-K
| $1.62 $1.96 | ▼ −20.99% | ▼ −17.22% | $2.32 (−43.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access